S100A8 accelerates wound healing by promoting adipose stem cell proliferation and suppressing inflammation

por Su, WeiGuo, Wang, PingLi, Dong, QiQiang, Li, ShengJun, Hu, ShuiWang
Publicado 2022

A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer

por Zhang, Yang, Wang, Zi‐Xian, Shen, Lin, Li, Jin, Huang, Jing, Su, Wei‐Guo, Zhang, Dong‐Sheng, Xu, Rui‐Hua
Publicado 2022

Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study

por Lu, Shun, Zhou, Jian-Ying, Niu, Xiao-Min, Zhou, Jian-Ya, Jian, Hong, Yin, Hong-Yan, Guan, Sha, Wang, Lin-Fang, Li, Ke, He, James, Su, Wei-Guo
Publicado 2021

Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study

por Xu, Jian Ming, Wang, Yan, Chen, Yu Ling, Jia, Ru, Li, Jie, Gong, Ji Fang, Li, Jing, Qi, Chuan, Hua, Ye, Tan, Cui Rong, Wang, Jian, Li, Ke, Sai, Yang, Zhou, Feng, Ren, Yong Xin, Qing, Wei Guo, Jia, Hong, Su, Wei Guo, Shen, Lin
Publicado 2017